BioRestorative Therapies regains compliance, reports Q1 2024 results

seekingalpha06-17

BioRestorative Therapies (NASDAQ:BRTX) has regained compliance with Nasdaq listing rule in connection with the filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2444169421?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-06-17 20:20","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2444169421","market":"sh","top_or_hot":-1,"title":"BioRestorative Therapies regains compliance, reports Q1 2024 results","media":"seekingalpha","content":"<div>\n<p>BioRestorative Therapies (NASDAQ:BRTX) has regained compliance with Nasdaq listing rule in connection with the filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024, ...</p>\n\n<a href=\"https://seekingalpha.com/news/4116596-biorestorative-therapies-regains-compliance-reports-q1-2024-results\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioRestorative Therapies regains compliance, reports Q1 2024 results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioRestorative Therapies regains compliance, reports Q1 2024 results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-17 20:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4116596-biorestorative-therapies-regains-compliance-reports-q1-2024-results><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BioRestorative Therapies (NASDAQ:BRTX) has regained compliance with Nasdaq listing rule in connection with the filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024, ...</p>\n\n<a href=\"https://seekingalpha.com/news/4116596-biorestorative-therapies-regains-compliance-reports-q1-2024-results\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BRTX","symbol_name":"BioRestorative Therapies, Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/4116596-biorestorative-therapies-regains-compliance-reports-q1-2024-results","article_id":"2444169421","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2444169421","pubTimestamp":1718626845,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"BioRestorative Therapies  has regained compliance with Nasdaq listing rule in connection with the filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024, with the SEC. For Q1, 2024, the Co. had a loss from operations of $4.1M, a 29% improvement from the $5.8M loss from operations for the comparable period of 2023.  The Co.’s net loss was $2.2M, or $0.33/share, compared to a net loss of $7.2M, or $1.93/share, for the comparable period in 2023. Cash used in operating activities was $2.3M, compared to $2.4M in Q1-2023. The Co. ended the Q1 in a strong financial position, with cash, cash equivalents, and investments held in marketable securities of $16.4M as of March 31, 2024.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BRTX":"BioRestorative Therapies, Inc.","BK4139":"生物科技"},"translate_title":"生物修复疗法恢复合规性，报告2024年第一季度业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BRTX":1},"content_text":"BioRestorative Therapies (NASDAQ:BRTX) has regained compliance with Nasdaq listing rule in connection with the filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024, with the SEC. For Q1, 2024, the Co. had a loss from operations of $4.1M, a 29% improvement from the $5.8M loss from operations for the comparable period of 2023.  The Co.’s net loss was $2.2M, or $0.33/share, compared to a net loss of $7.2M, or $1.93/share, for the comparable period in 2023. Cash used in operating activities was $2.3M, compared to $2.4M in Q1-2023. The Co. ended the Q1 in a strong financial position, with cash, cash equivalents, and investments held in marketable securities of $16.4M as of March 31, 2024.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2444169421"}